Weak 1Q23 as expected; Expect multiple drivers from iPhone/CPU socket/400G/EV in 2H23E
Turnaround is here but weaker than expected
China Policy:Credit growth is expected to rebound in 2023
–1H23 worse than expected on slow recovery; Maintain HOLD
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
ESOP targets stabilize earnings expectation but sentiment overhang remains
Expect Shengyi to enter Nvidia supply chain in 2024
3Q NPAT boosted by net fair value gains; expect resilient full-year NBV upswing
China Property SectorNBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
Expect domestic business to rebound from 2025